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SUMMARY
US public health laboratories began reporting Escherichia coli O157 isolates to CDC in 1996. We 
describe temporal and geographical patterns of isolates reported from 1996 to 2011 and 
demographics of persons whose specimens yielded isolates. We calculated annual E. coli O157 
isolation rates/100000 persons by patient’s state of residence, county of residence, age, and sex 
using census data. The average annual isolation rate was 0·84. The average isolation rate in 
northern states (1·52) was higher than in southern states (0·43). Counties with ≥76% rural 
population had a lower isolation rate (0·67) than counties with ≤ 25%, 26–50%, and 51–75% rural 
populations (0·81, 0·92, and 0·81, respectively). The highest isolation rate (3·19) was in children 
aged 1–4 years. Infections were seasonal with 49% of isolates collected during July to September. 
Research into reasons for higher incidence in northern states and for seasonality could guide 
strategies to prevent illnesses.
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INTRODUCTION
Escherichia coli O157 causes an estimated 96000 illnesses annually in the USA [1]. 
Infections typically result in severe abdominal cramping and diarrhoea, which is often 
bloody [2]. Complications include haemolytic uraemic syndrome (HUS) and death.
E. coli O157 infection became nationally notifiable in the USA in 1994, and passive, 
national Laboratory-based Enteric Disease Surveillance (LEDS) began collecting 
information on laboratory-confirmed isolates in 1996. We used these data to describe 
temporal and geographical patterns of E. coli O157 isolates reported to the US Centers for 
Disease Control and Prevention (CDC) from 1996 to 2011 and the demographics of the 
persons whose clinical specimens yielded the isolates.
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METHODS
We evaluated data on E. coli O157 isolates reported by state public health laboratories to 
CDC from 1996 to 2011. Clinical laboratories in all 50 states and territories are requested 
(and, in some states, required) to forward clinical isolates of E. coli O157 to their state 
public health department laboratory. State public health laboratories send reports containing 
information on patient’s sex, age, race, ethnicity, and county and state of residence, as well 
as specimen source, serotype, and date of collection. Reports are sent electronically to CDC. 
Isolates with the same state identifiers that also match by age, state, and specimen source 
and have specimen isolation dates within 30 days of one another are considered duplicates 
and discarded.
We calculated average annual E.coli O157 isolation rates/100000 persons by patient’s state 
of residence (including District of Columbia), age, and sex using intercensal population 
estimates from the US Census Bureau. We used the 37th parallel north to define northern 
and southern states because it is conveniently the official border of multiple states. We 
defined a southern state as any state entirely south of the 37th parallel north and the 
remainder as northern states. In the analysis of northern vs. southern states, we excluded (1) 
Alaska and Hawaii, because they are not part of the contiguous USA, and (2) California and 
Nevada, because a large proportion of their population is on both sides of the 37th parallel 
north.
To explore urban/rural differences in annual E. coli O157 isolation rates, we analysed the 
data by census-derived categories of counties based on percentage of the population residing 
in a rural area: 425%, 26–50%, 51–75%, and 576%. We constructed standard and zero-
inflated Poisson and negative binomial regression models. The zero-inflated count 
regression models account for the possibility that zero illness counts reported by some 
counties are related not to a true lack of illness, but to detection or reporting that is less 
complete than in other counties [3]. We conducted the analysis on all 3141 counties. To 
exclude counties that may have been more likely to have incomplete reporting, we also 
conducted the analysis on a dataset that excluded counties with a population <1000 and 
those that did not report any Salmonella or E. coli O157 isolates during the 16-year period. 
We then selected a best model based on quality of fit and epidemiology, and report estimated 
isolation rates by rural category with their 95% confidence intervals (CIs).
Data were analysed using SAS v. 9.3 (SAS Institute Inc., USA).
RESULTS
During 1996–2011, CDC received reports of 38895 laboratory-confirmed E. coli O157 
isolates from all 50 states and the District of Columbia. Of these, 36841 (95%) were 
identified as O157:H7. Of the 35095 isolates with known sources, 33886 (97%) were from 
stool specimens and the remainder were from other sources including urine (163, 0·5%), 
blood (91, 0·3%), and wounds or abscesses (40, 0·1%). The average annual isolation rate 
nationally was 0·84/100000 persons. In 1996, the isolation rate was 0·71/100 000 persons, 
which decreased to 0·62/100000 persons in 1997 (Fig. 1). Isolation rates then steadily 
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increased to a peak of 1·29/100000 persons in 2000, followed by a decline to 0·76/100000 
persons in 2004. From 2004–2011, isolation rates were relatively stable with the exception 
of increases in 2006 and 2008.
Of the isolates with patient data available, 53% were from female patients and the median 
age in patients was 15 (range 0–108) years. Comparatively, the median age of the general 
population was 37 years in 2010 [4]. Based on the 33937 (87%) isolates with known 
patient’s age and sex data, the highest isolation rate (3·19/100000 persons) was in children 
aged 1–4 years (Table 1). The rate declined with increasing age to a nadir of 0·30/100 000 
persons in those aged 30–39 years, then steadily increased to 0·62/100 000 persons in those 
aged 70–79 years and was similar (0·58) in patients aged ≥80 years.
For children other than infants (aged <12 months), laboratory-confirmed isolation rates were 
higher in boys than girls (Table 1). For infants and those in age groups 520–29 years, the 
rates were higher in females than males.
In the contiguous USA, the average annual isolation rate was 1·52/100000 persons in states 
in the north and 0·43 in states in the south. All states with an average annual isolation rate 
>1·0 were in the north (Fig. 2).
For the rurality analysis, we found significant over-dispersion of illness counts relative to 
simple Poisson regression. In 3141 counties, 35% never reported anE. coli O157 isolate over 
the 16-year time span; 56% of the non-reporting counties had 576% rural populations. We 
examined the occurrence of many zero illness counts in zero-inflated and other models, and 
found no evidence of zero inflation. A negative binomial regression model had the best fit. 
The model applied to the complete dataset estimated isolation rates in counties with 425%, 
26–50%, 51–75%, and 576% rural populations as 0·81 (95% CI 0·73–0·89), 0·92 (95% CI 
0·84–1·0), 0·81 (95% CI 0·74–0·88), and 0·67 (95% CI 0·61–0·73)/100000 persons, 
respectively. We found similar results when this model was applied to the dataset that 
excluded the 105 (3%) counties that may have been more likely to have incomplete 
reporting.
Infections were sharply seasonal, with 49% of isolates collected during July–September and 
only 9% during January–March (Fig. 3). This summer predominance was similarly present 
in both northern and southern regions.
DISCUSSION
This study is the first to evaluate longitudinal US national data on E. coli O157 infections 
and highlights the value of national surveillance programmes to evaluate geographically 
disperse data. Isolation rates were highest in northern states, during summer months, and in 
children aged 1–4 years.
The reason that states in the northernmost latitudes have higher incidence rates is not known, 
but this finding is consistent with other studies and reports [2, 5]. A multicentre hospital-
based study during 1990–1992 reported a northern predominance [2], and the northernmost 
Foodborne Diseases Active Surveillance System (Food Net) sites have reported a higher 
SODHA et al. Page 3
Epidemiol Infect. Author manuscript; available in PMC 2019 May 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
incidence than other sites [6], even after adjusting for outbreaks and testing practices [7]. In 
addition, analysis of outbreak data indicates a higher rate of outbreaks in northern than in 
southern states (CDC, unpublished data). This increasing incidence with increasing 
proximity to the poles may be a global phenomenon. Within continental Europe, reported 
rates tend to be higher in northern European countries, such as Germany and The 
Netherlands, than in southern European countries, such as Spain and Italy [8]. In addition, in 
the UK and North America, incidence is highest in the northernmost countries, Scotland and 
Canada, respectively [9]. Conversely, in the southern hemisphere, higher rates of illness tend 
to be reported from the more southerly nations. For example, Argentina, which has a high 
cattle density, has the highest reported incidence rates of HUS globally; most of Argentina’s 
HUS cases are caused by Shiga toxin-producing E. coli infection, and the predominant sero 
group is E. coli O157 [10, 11]. The southern Africa region was among the first areas to 
report HUS cases [12] and reported the largest E. coli. coli.E.coli O157 outbreak in Africa 
[13]. A latitude effect suggests a climatic role in transmission of E. coli O157 or shedding in 
cattle, the primary reservoir [14]. Number of daylight hours has been reported to correlate 
positively with increased shedding of E. coli O157 by cattle. In an experimental study, cattle 
exposed daily for 60 days to ~ 12 h of natural light followed by an additional 5 h of artificial 
light were found to shed more E. coli O157 organisms than cattle exposed only to the 12 h 
of natural light [15]. These authors suggested a possible role of melatonin, a hormone with 
seasonal fluctuations and possible effects on the immune system. Such a mechanism may 
explain our findings, given the longer daylight hours in northern than southern states in the 
USA during the summer.
Other possible reasons for our geographical findings include geographical differences in 
animal carriage, meat processing, or urbanization. In addition, environmental factors 
including water sources and cattle density may play a role. Studies in Canada and Germany 
found cattle density to be positively associated with incidence of E. coli O157 infections in 
humans [16–18]. For this reason, we expected to find higher isolation rates in rural counties 
but instead found the lowest rate in the group of counties with the highest rural population. 
A large proportion of rural counties did not report a single case over the 16-year period. It is 
possible that persons in rural counties are less likely to have a stool cultured, or that clinical 
laboratories that serve rural areas test fewer samples for E. coli O157 or report cases less 
consistently; if so, our finding may be an artifact of diagnosis or surveillance. However, we 
found no evidence that non-reporting counties influenced our findings. Our finding is 
plausible if persons in rural counties have many opportunities for low-level exposure that 
results in immunological protection without clinical illness. An estimated 68% of E. coli 
O157 infections nationally are transmitted by food, so rural residence may not have a large 
role in determining variation in rates of illness [1].
Consistent with other reports [2, 19], we found that infections were most common in the 
summer months. While a study based on FoodNet Population Survey data found no seasonal 
variation in ground beef consumption patterns [20], a higher proportion of cattle shed E. coli 
O157 during the summer months [21], which probably relates to the increased prevalence of 
E. coli O157 contamination of beef during those months [22]. In addition, other modes of 
transmission such as waterborne and direct animal contact may also be affected by this 
increased shedding.
SODHA et al. Page 4
Epidemiol Infect. Author manuscript; available in PMC 2019 May 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Incidence was highest in children aged 1–4 years. Person-to-person transmission has been 
well documented, accounting for 14% of US E. coli O157 outbreaks from 1982 to 2002, 
mostly in child daycare centres [23]. Hygienic factors may result in more frequent exposure 
in children, and immunological susceptibility may also play an important role.
Sources of E. coli O157 infection include food, particularly ground beef, water, contact with 
animals or their environment, and direct contact with another person or fomite [23]. Most 
prevention efforts have focused on decreasing the contamination of ground beef. The decline 
in incidence from 2000 to 2003 mirrored the 76% decline in contamination of ground beef 
samples with E. coli O157 from 2000 to 2004 [24].
The pattern of isolation rates observed in our data, including the decrease in incidence from 
2000 to 2004, correlates well with trends in FoodNet sites, which included 15% of the US 
population in 2009 [5]. The increase in incidence from 1996 to 2000 may be due to 
increased testing by clinical laboratories [25]. In 2002, in response to continued outbreaks 
and ground beef recalls, USDA tightened regulations and the beef grinding industry made 
changes that were followed by marked declines in 2003 and 2004 in the proportion of 
ground beef samples that yielded E. coli O157 which possibly contributed to decreasing 
incidence [26, 27]. The spikes in incidence in 2006 and 2008 may reflect actual increases in 
illnesses but could have been related to increased testing related to several large, multistate 
outbreaks. In 2006, an outbreak of E. coli O157 infections from contaminated spinach 
resulted in 205 illnesses in 26 states [28, 29]. In 2008, a widespread outbreak of Salmonella 
serotype Saintpaul infections associated mostly with contaminated jalapeño and Serrano 
peppers caused 1500 illnesses in 43 states [30]. The increased awareness and publicity 
caused by these outbreaks may have led to increased patient visits and increased stool testing 
by physicians.
We did not calculate confidence intervals in our analysis because the surveillance system is 
designed to capture all isolates reported at the national level and does not represent a subset 
of isolates (e.g. National Antimicrobial Resistance Monitoring System) or of the population 
(e.g. FoodNet). Therefore, with no sampling within the surveillance system, there are no 
appropriate statistical methods to assess the uncertainty within it.
There are still limitations to the interpretation of these data. First, only persons with illness 
severe enough for the person to seek medical care and for which the provider ordered 
cultures are represented. Second, the completeness of reporting varies between states 
because public health requirements and infrastructure vary at the state and local level. 
Because our results correlate with trends found in FoodNet, this variation in reporting 
appears to have had a minimal effect on the evaluation of national patterns but does dictate 
caution in the interpretation of state and regional data. This is particularly an issue with 
Maine, Nebraska, Texas, and Wyoming; after 2006, these states began using a reporting 
system from which serogroup information could not be retrieved. There is also variability in 
information provided to the surveillance system. For example, nearly 13% of reports lacked 
age and gender information. However, there is no evidence on the extent that this may have 
biased the patterns related to age or gender.
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Prevention of E. coli O157 infections depends on understanding mechanisms of 
transmission. Further research into decreasing carriage and shedding by cattle, preventing 
contamination of beef and other foods such as produce, and better understanding of the 
reasons for the higher incidence in northern states and for the summer seasonality could help 
in developing strategies to prevent illnesses. Analyses that estimate the proportion of 
illnesses attributable to specific foodborne (e.g. ground beef, leafy vegetables) and non-
foodborne transmission routes could help in targeting prevention efforts.
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Fig.1. 
Annual isolation of E. coli O157, USA, Laboratory-based Enteric Disease Surveillance, 
1996–2011.
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Fig. 2. 
Average annual isolation rate of E. coli O157 by state, USA, Laboratory-based Enteric 
Disease Surveillance, 1996–2011 (n=38895).
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Fig. 3. 
Number of E. coli O157 isolates by month, USA, Laboratory-based Enteric Disease 
Surveillance, 1996–2011 (n=38895).
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